Gene therapy for ovarian cancer
- PMID: 11589066
Gene therapy for ovarian cancer
Abstract
Advances in molecular virology and biotechnology have led to the engineering of vectors that can efficiently transfer genes to target cells. Gene therapy strategies were developed along two lines: Cytotoxic approaches involve the transfer of genes that encode enzymes, which convert inactive prodrugs into cytotoxic drugs. Corrective gene therapy approaches aim to repair specific molecular alterations in signal transduction mechanisms that control the cell cycle or induce apoptosis. Clinical evidence suggests that gene therapies are best suited for patients with minimal residual disease. Multimodality approaches with conventional strategies and novel therapeutic tools in various combinations will most likely prove advantageous, compared to single-modality treatments. However, clinical trials will need to test these hypotheses.
Similar articles
-
Advances in adenovirus-mediated p53 cancer gene therapy.Expert Opin Biol Ther. 2013 Nov;13(11):1569-83. doi: 10.1517/14712598.2013.845662. Expert Opin Biol Ther. 2013. PMID: 24107178
-
[Gene therapy and ovarian cancer: update of clinical trials].J Gynecol Obstet Biol Reprod (Paris). 2000 Oct;29(6):532-7. J Gynecol Obstet Biol Reprod (Paris). 2000. PMID: 11084459 Review. French.
-
Gene therapy for ovarian cancer: progress and potential.Hematol Oncol Clin North Am. 2003 Aug;17(4):1021-50. doi: 10.1016/s0889-8588(03)00055-8. Hematol Oncol Clin North Am. 2003. PMID: 12959190 Review.
-
From gene therapy to virotherapy for ovarian cancer.Minerva Ginecol. 2004 Dec;56(6):503-14. Minerva Ginecol. 2004. PMID: 15729203 Review.
-
Targeted gene therapy for ovarian cancer.Curr Gene Ther. 2005 Dec;5(6):643-53. doi: 10.2174/156652305774964668. Curr Gene Ther. 2005. PMID: 16457653 Review.
Cited by
-
The current state of head and neck cancer gene therapy.Hum Gene Ther. 2009 Dec;20(12):1565-75. doi: 10.1089/hum.2009.163. Hum Gene Ther. 2009. PMID: 19747066 Free PMC article. Review.
-
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.J Immunother. 2011 May;34(4):343-52. doi: 10.1097/CJI.0b013e3182187600. J Immunother. 2011. PMID: 21499127 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical